| Year |
Citation |
Score |
| 2023 |
Atwell B, Chalasani P, Schroeder J. Nuclear epidermal growth factor receptor as a therapeutic target. Exploration of Targeted Anti-Tumor Therapy. 4: 616-629. PMID 37720348 DOI: 10.37349/etat.2023.00156 |
0.438 |
|
| 2022 |
Atwell B, Chen CY, Christofferson M, Montfort WR, Schroeder J. Sorting nexin-dependent therapeutic targeting of oncogenic epidermal growth factor receptor. Cancer Gene Therapy. PMID 36253541 DOI: 10.1038/s41417-022-00541-7 |
0.491 |
|
| 2022 |
Frankman ZD, Jiang L, Schroeder JA, Zohar Y. Application of Microfluidic Systems for Breast Cancer Research. Micromachines. 13. PMID 35208277 DOI: 10.3390/mi13020152 |
0.425 |
|
| 2021 |
Tsutsumi E, Stricklin J, Peterson EA, Schroeder JA, Kim S. Cxcl10 chemokine induces migration of ING4-deficient breast cancer cells via a novel crosstalk mechanism between the Cxcr3 and Egfr receptors. Molecular and Cellular Biology. MCB0038221. PMID 34871062 DOI: 10.1128/MCB.00382-21 |
0.579 |
|
| 2019 |
Maisel SA, Broka D, Atwell B, Bunch T, Kupp R, Singh SK, Mehta S, Schroeder J. Stapled EGFR peptide reduces inflammatory breast cancer and inhibits additional HER-driven models of cancer. Journal of Translational Medicine. 17: 201. PMID 31215437 DOI: 10.1186/S12967-019-1939-7 |
0.538 |
|
| 2019 |
Maisel SA, Schroeder J. Wrong place at the wrong time: how retrograde trafficking drives cancer metastasis through receptor mislocalization Journal of Cancer Metastasis and Treatment. 2019. DOI: 10.20517/2394-4722.2018.82 |
0.463 |
|
| 2017 |
Maisel S, Broka D, Schroeder J. Intravesicular epidermal growth factor receptor subject to retrograde trafficking drives epidermal growth factor-dependent migration. Oncotarget. 9: 6463-6477. PMID 29464085 DOI: 10.18632/Oncotarget.23766 |
0.567 |
|
| 2017 |
Daniel SG, Russ AD, Guthridge KM, Raina AI, Estes PS, Parsons LM, Richardson HE, Schroeder JA, Zarnescu DC. miR-9a mediates the role of Lethal giant larvae as an epithelial growth inhibitor in Drosophila. Biology Open. PMID 29361610 DOI: 10.1242/Bio.027391 |
0.368 |
|
| 2017 |
Schroeder JA, Maisel S, Broka D. Abstract 1346: Pan-ERBB inhibitor blocks tumor growth and metastasis Cancer Research. 77: 1346-1346. DOI: 10.1158/1538-7445.Am2017-1346 |
0.412 |
|
| 2016 |
Greenwood E, Maisel S, Ebertz D, Russ A, Pandey R, Schroeder J. Llgl1 prevents metaplastic survival driven by epidermal growth factor dependent migration. Oncotarget. PMID 27542214 DOI: 10.18632/Oncotarget.11320 |
0.433 |
|
| 2016 |
Buehler J, Zeltzer S, Reitsma J, Petrucelli A, Umashankar M, Rak M, Zagallo P, Schroeder J, Terhune S, Goodrum F. Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication. Plos Pathogens. 12: e1005655. PMID 27218650 DOI: 10.1371/Journal.Ppat.1005655 |
0.432 |
|
| 2016 |
Greenwood E, Ebertz D, Fabiano A, Schroeder JA. Abstract A16: Loss of Hugl1 induces an EGF-dependent cellular transdifferentiation Molecular Cancer Research. 14. DOI: 10.1158/1557-3125.Advbc15-A16 |
0.528 |
|
| 2014 |
Zheng X, Jiang L, Schroeder J, Stopeck A, Zohar Y. Isolation of viable cancer cells in antibody-functionalized microfluidic devices. Biomicrofluidics. 8: 024119. PMID 24803968 DOI: 10.1063/1.4873956 |
0.446 |
|
| 2013 |
Hart MR, Su HY, Broka D, Goverdhan A, Schroeder JA. Inactive ERBB receptors cooperate with reactive oxygen species to suppress cancer progression. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 1996-2007. PMID 24081029 DOI: 10.1038/Mt.2013.196 |
0.789 |
|
| 2013 |
Horm TM, Schroeder JA. MUC1 and metastatic cancer: expression, function and therapeutic targeting. Cell Adhesion & Migration. 7: 187-98. PMID 23303343 DOI: 10.4161/Cam.23131 |
0.766 |
|
| 2013 |
Horm TM, Bitler BG, Broka DM, Louderbough J, Schroeder JA. Abstract A78: MUC1 drives c-Met-dependent migration and scattering Cancer Research. 73. DOI: 10.1158/1538-7445.Tim2013-A78 |
0.792 |
|
| 2012 |
Horm TM, Bitler BG, Broka DM, Louderbough JM, Schroeder JA. MUC1 drives c-Met-dependent migration and scattering. Molecular Cancer Research : McR. 10: 1544-54. PMID 23193156 DOI: 10.1158/1541-7786.Mcr-12-0296 |
0.795 |
|
| 2012 |
Russ A, Louderbough JM, Zarnescu D, Schroeder JA. Hugl1 and Hugl2 in mammary epithelial cells: polarity, proliferation, and differentiation. Plos One. 7: e47734. PMID 23110097 DOI: 10.1371/Journal.Pone.0047734 |
0.473 |
|
| 2011 |
Louderbough JM, Brown JA, Nagle RB, Schroeder JA. CD44 Promotes Epithelial Mammary Gland Development and Exhibits Altered Localization during Cancer Progression. Genes & Cancer. 2: 771-81. PMID 22393462 DOI: 10.1177/1947601911428223 |
0.462 |
|
| 2011 |
Louderbough JM, Schroeder JA. Understanding the dual nature of CD44 in breast cancer progression. Molecular Cancer Research : McR. 9: 1573-86. PMID 21970856 DOI: 10.1158/1541-7786.Mcr-11-0156 |
0.416 |
|
| 2011 |
Zheng X, Cheung LS, Schroeder JA, Jiang L, Zohar Y. Cell receptor and surface ligand density effects on dynamic states of adhering circulating tumor cells. Lab On a Chip. 11: 3431-9. PMID 21853194 DOI: 10.1039/C1Lc20455F |
0.377 |
|
| 2011 |
Zheng X, Cheung LS, Schroeder JA, Jiang L, Zohar Y. A high-performance microsystem for isolating circulating tumor cells. Lab On a Chip. 11: 3269-76. PMID 21837324 DOI: 10.1039/C1Lc20331B |
0.41 |
|
| 2011 |
Cheung LSL, Zheng X, Wang L, Baygents JC, Guzman R, Schroeder JA, Heimark RL, Zohar Y. Adhesion dynamics of circulating tumor cells under shear flow in a bio-functionalized microchannel Journal of Micromechanics and Microengineering. 21. DOI: 10.1088/0960-1317/21/5/054033 |
0.417 |
|
| 2010 |
Flowers M, Schroeder JA, Borowsky AD, Besselsen DG, Thomson CA, Pandey R, Thompson PA. Pilot study on the effects of dietary conjugated linoleic acid on tumorigenesis and gene expression in PyMT transgenic mice. Carcinogenesis. 31: 1642-9. PMID 20624750 DOI: 10.1093/Carcin/Bgq148 |
0.422 |
|
| 2010 |
Bitler BG, Goverdhan A, Schroeder JA. MUC1 regulates nuclear localization and function of the epidermal growth factor receptor Journal of Cell Science. 123: 1716-1723. PMID 20406885 DOI: 10.1242/Jcs.062661 |
0.746 |
|
| 2010 |
Louderbough JMV, Lopez JI, Schroeder JA. Matrix hyaluronan alters epidermal growth factor receptor-dependent cell morphology Cell Adhesion and Migration. 4: 26-31. PMID 20009574 DOI: 10.4161/Cam.4.1.10252 |
0.449 |
|
| 2010 |
Bitler BG, Schroeder JA. Anti-cancer therapies that utilize cell penetrating peptides Recent Patents On Anti-Cancer Drug Discovery. 5: 99-108. PMID 19961434 DOI: 10.2174/157489210790936252 |
0.672 |
|
| 2010 |
Bitler BG, Goverdhan A, Schroeder J. Abstract 270: Modulation of EGFR localization and transcriptional activity Cancer Research. 70: 270-270. DOI: 10.1158/1538-7445.Am10-270 |
0.757 |
|
| 2010 |
Su H, Schroeder JA. Abstract 266: The interaction between MUC1 and erbB3 promotes erbB3 signaling and cell survival Cancer Research. 70: 266-266. DOI: 10.1158/1538-7445.Am10-266 |
0.817 |
|
| 2010 |
Cheung LSL, Zheng X, Wang L, Guzman R, Schroeder JA, Heimark RL, Baygents JC, Zohar Y. Kinematics of specifically captured circulating tumor cells in bio-functionalized microchannels Journal of Microelectromechanical Systems. 19: 752-763. DOI: 10.1109/Jmems.2010.2052021 |
0.373 |
|
| 2009 |
Cheung LS, Zheng X, Stopa A, Baygents JC, Guzman R, Schroeder JA, Heimark RL, Zohar Y. Detachment of captured cancer cells under flow acceleration in a bio-functionalized microchannel. Lab On a Chip. 9: 1721-31. PMID 19495456 DOI: 10.1039/B822172C |
0.351 |
|
| 2009 |
Bitter BG, Menzl I, Huerta CL, Sands B, Knowlton W, Chang A, Schroeder JA. Intracellular MUC1 peptides inhibit cancer progression Clinical Cancer Research. 15: 100-109. PMID 19118037 DOI: 10.1158/1078-0432.Ccr-08-1745 |
0.621 |
|
| 2008 |
Louderbough J, Schroeder JA. EGFR‐induced EMT is modulated by the ECM: the role of hyaluronan in the inhibition of breast cancer metastasis The Faseb Journal. 22: 21-21. DOI: 10.1096/Fasebj.22.2_Supplement.21 |
0.504 |
|
| 2007 |
Pochampalli MR, Bitler BG, Schroeder JA. Transforming growth factor α-dependent cancer progression is modulated by Muc1 Cancer Research. 67: 6591-6598. PMID 17638868 DOI: 10.1158/0008-5472.Can-06-4518 |
0.739 |
|
| 2007 |
Pochampalli MR, Bejjani RME, Schroeder JA. MUC1 is a novel regulator of ErbB1 receptor trafficking Oncogene. 26: 1693-1701. PMID 16983337 DOI: 10.1038/Sj.Onc.1209976 |
0.748 |
|
| 2005 |
Lopez JI, Camenisch TD, Stevens MV, Sands BJ, McDonald J, Schroeder JA. CD44 attenuates metastatic invasion during breast cancer progression. Cancer Research. 65: 6755-63. PMID 16061657 DOI: 10.1158/0008-5472.Can-05-0863 |
0.456 |
|
| 2004 |
Schroeder JA, Masri AA, Adriance MC, Tessier JC, Kotlarczyk KL, Thompson MC, Gendler SJ. MUC1 overexpression results in mammary gland tumorigenesis and prolonged alveolar differentiation. Oncogene. 23: 5739-47. PMID 15221004 DOI: 10.1038/Sj.Onc.1207713 |
0.48 |
|
| 2004 |
Hattrup CL, Fernandez-Rodriguez J, Schroeder JA, Hansson GC, Gendler SJ. MUC1 can interact with adenomatous polyposis coli in breast cancer. Biochemical and Biophysical Research Communications. 316: 364-9. PMID 15020226 DOI: 10.1016/J.Bbrc.2004.02.072 |
0.531 |
|
| 2003 |
Schroeder JA, Jackson LF, Lee DC, Camenisch TD. Form and function of developing heart valves: coordination by extracellular matrix and growth factor signaling. Journal of Molecular Medicine (Berlin, Germany). 81: 392-403. PMID 12827270 DOI: 10.1007/S00109-003-0456-5 |
0.386 |
|
| 2003 |
Schroeder JA, Adriance MC, Thompson MC, Camenisch TD, Gendler SJ. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene. 22: 1324-32. PMID 12618757 DOI: 10.1038/Sj.Onc.1206291 |
0.467 |
|
| 2002 |
Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA. Heart-valve mesenchyme formation is dependent on hyaluronan-augmented activation of ErbB2-ErbB3 receptors. Nature Medicine. 8: 850-5. PMID 12134143 DOI: 10.1038/Nm742 |
0.384 |
|
| 2002 |
Schroeder JA, Adriance MC, McConnell EJ, Thompson MC, Pockaj B, Gendler SJ. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. The Journal of Biological Chemistry. 277: 22692-8. PMID 11950845 DOI: 10.1074/Jbc.M201975200 |
0.507 |
|
| 2001 |
Schroeder JA, Thompson MC, Gardner MM, Gendler SJ. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. The Journal of Biological Chemistry. 276: 13057-64. PMID 11278868 DOI: 10.1074/Jbc.M011248200 |
0.581 |
|
| 2000 |
Schroeder JA, Troyer KL, Lee DC. Cooperative induction of mammary tumorigenesis by TGFα and Wnts Oncogene. 19: 3193-3199. PMID 10918574 DOI: 10.1038/Sj.Onc.1203652 |
0.379 |
|
| 1997 |
Schroeder JA, Lee DC. Transgenic mice reveal roles for TGFα and EGF receptor in mammary gland development and neoplasia Journal of Mammary Gland Biology and Neoplasia. 2: 119-129. PMID 10882298 DOI: 10.1023/A:1026347629876 |
0.445 |
|
| Show low-probability matches. |